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Objective: The aim of this study was to examine the quality of life of breast cancer patients 
  medicated with estrogen antagonists, 2 years after having acupuncture treatment for hot 
flashes.
Methods and materials: Our sample was taken from women who had recently participated in 
a randomized controlled trial investigating the effects of acupuncture on hot flashes, a side effect 
of estrogen-antagonist treatment. Forty-one women from the true acupuncture treatment group 
and 41 women from the control group (sham acupuncture), who had 2 years previously received 
a course of 15 acupuncture treatments over a period of 10 weeks, were asked to answer an open 
question. The question, “Would you like to share your thoughts and experiences related to your 
breast cancer diagnosis, treatments or anything else?” was by being open, broad, and nonspecific, 
intended to stimulate subjective information, which was not included in the original, or future 
quantitative studies. Qualitative data were analyzed using systematic text condensation.
Results: Most women were troubled by two or more side effects due to anti-estrogen medication, 
negatively affecting their life quality. Symptoms included hot flashes, sleep problems, muscle 
and joint pain, arm edema, fatigue, weight gain, depression, and lack of sexual desire. Women 
previously treated with sham acupuncture complained that hot flashes were still problematic, 
whilst those previously treated with traditional Chinese acupuncture found them less of a problem 
and generally had a more positive outlook on life. These results compare favorably with the 
findings from our original study that measured quantitatively health related quality of life.
Conclusion: Side effects due to anti-estrogen treatment seriously affect the quality of life 
of breast cancer operated patients. Patients who had previously been treated with traditional 
Chinese acupuncture complained less of hot flashes, and had a more positive outlook on life, 
than women who had previously been treated with sham acupuncture.
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Introduction
The aim of our study was to examine the quality of life of breast cancer operated 
patients, treated with estrogen antagonists, 2 years after acupuncture treatment. By 
posing an open, broad, and nonspecific question about experiences related to breast 
cancer diagnosis and treatment, we hoped to gather subjective information from this 
patient group, not normally included in quantitative outcome measures.
There were around 430,000 new cases of breast cancer in Europe in 2008; 55% of 
these were estrogen-receptor positive.1 Conventional medical treatment involves the use 
of hormone therapy for those diagnosed with estrogen-sensitive tumors, for a minimum 
of 5 years. Drugs include the estrogen antagonist tamoxifen and aromatase   inhibitors International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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such as anastrozole, exemestane, and letrozole. Many women 
suffer from side effects, the most common being hot flashes, 
affecting around 80% of women taking tamoxifen.2 The 
severity of hot flashes has been shown to be more severe 
and intense than those experienced by healthy menopausal 
women.3,4 The use of hormone replacement therapy, an option 
for healthy women, is contraindicated in estrogen-sensitive 
breast cancer patients. Pharmacological agents used to treat 
hot flashes, eg, antihypertensive clonidin, steroids, and anti-
depressants, often have adverse effects, such as hypotension, 
weight gain, and nausea respectively.5 A study from Henry 
Ford Hospital, Detroit randomized 50 women with breast 
cancer to either acupuncture or venlafaxine treatment over 
a period of 12 weeks; patients were followed up for 1 year. 
Results showed that acupuncture appeared to be as effective 
in reducing hot flashes as   venlafaxine, an antidepressive 
medication.6
The authors of this study have previously carried out 
a randomized, controlled trial, investigating the effects of 
acupuncture treatment in breast cancer operated patients 
complaining of hot flashes.7 Results from the trial showed a 
significant reduction in number of hot flashes both day and 
night, coupled with a significant improvement in health-
related life quality that lasted for a further 3 months post 
treatment in patients receiving traditional Chinese medicine 
(TCM) acupuncture. The only significant effect, experienced 
by patients in the sham acupuncture group, was a reduction in 
hot flashes at night during treatment; however, the effect did 
not last throughout the following 3 months. We concluded 
that acupuncture was a valuable option for this patient group 
suffering from side effects due to long-term anti-estrogen 
medication. However, the effect of acupuncture treatment 
beyond 3 months was not investigated.
In an attempt to accumulate qualitative information 
related to health and life quality from women who had 
been diagnosed and treated for breast cancer, the authors 
devised an open question: “Would you like to share your 
thoughts and experiences related to your breast cancer 
diagnosis, treatments, or anything else?” Although all 
patients had received acupuncture 2 years previously, the 
question put to them did not specifically mention acupunc-
ture treatment. This deliberate emission was an attempt to 
avoid leading them in a specific direction regarding their 
statements, allowing them to give information important 
to them, whether it was centered around their breast cancer 
diagnosis, various treatments, social issues, or indeed other 
aspects of life.   Acupuncture studies investigating hot flashes, 
in both women with breast cancer, and healthy women, 
have recorded changes in health outside expected outcome 
measures.8 We hoped that   accumulation of subjective infor-
mation would provide us with a broader understanding of 
the quality of life, including physiological, psychological, 
emotional, and social elements for these women. An Iranian 
literature review from 1982 to 2008, examined the relation-
ship between quality of life and survival time in cancer 
patients. Quality of life data were shown to be significant 
predictors of survival duration.9 Quality of life is a term 
which only became a medical issue in the 1960s, and is 
defined by WHO as “how an individual perceives his own 
life, in light of the cultural context and values of his envi-
ronment, aims, expectations and worries”.10 Indeed, TCM 
embraces these interactions. All the women included in our 
study had been primarily treated with traditional Western 
medicine; Chinese medicine was used to reduce side effects 
of western medication.
Design, materials and methods
Patients
To gain subjective information from this patient group, 
a qualitative design was considered applicable. Data were 
gathered from participants’ written answers to an open ques-
tion, sent in the post, accompanied by an explanatory letter. 
Our sample was taken from a previous randomized con-
trolled trial which included 59 Norwegian female patients. 
All patients had been recruited from The Breast Centre at 
Vestfold Central Hospital. Because a third of these were 
not reachable, a further 31 women were included; these 
women were comparable to the women originally included 
in the study, in age and in social and drinking habits. 
Baseline values of mean numbers of hot flashes at day and 
night, and total Kupperman index score, measuring health-
related quality of life, were not significantly different, and 
they were treated and followed up in an identical manner 
to those included originally. All patients were randomized 
by a closed envelope technique to 15 standard treatments 
with TCM acupuncture or sham (minimal) acupuncture, and 
monitored for a further 12 weeks after completing treatment. 
All participants had been medicated with tamoxifen for at 
least 3 months, and were postmenopausal, defined as no 
menstruation for at least 3 months before treatment start. 
Patients taking medication for hot flashes either prior to or 
during the study were excluded. Further exclusion criteria 
included: previous acupuncture, simultaneous treatment with 
other complementary or alternative therapies, and serious 
systemic or psychological disorders. No hot flash severity 
limits were implemented.International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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Methods
A total of 82 patients received an invitation to take part, and 
a questionnaire in the post, 2 years (±2 months) after finish-
ing the acupuncture course of treatments. Forty-one patients 
had previously received TCM acupuncture, and 41 patients 
had received sham acupuncture (control group). Patients had 
been blinded to the type of treatment they had received in 
the original study, and had not at any point in time received 
any information indicating what type of treatment they had 
received prior to writing their statements. The study was 
approved by the regional committee for medical research 
ethics.
Analysis of data
Content analysis was done by reading and rereading the 
material to gain an overall impression. Simple counting of the 
number of women who referred to different aspects of their 
diagnosis, treatment, and daily life was undertaken. Groups 
making similar statements were indexed to develop ana-
lytical categories and were derived inductively to produce a 
grounded theory, developing a hypothesis from the collected 
data rather than defining it beforehand. To develop catego-
ries, interesting or unfamiliar terms were noted. All relevant 
data from each category were identified and examined using 
constant comparison; categories were added to reflect as 
many nuances in the data as possible. Categories were further 
refined and grouped together by using spreadsheets and the 
split-screen function of word-processing, creating key themes 
and categories for further investigation. Although researcher 
bias was not considered a problem, two analysts were used; 
neither patient identity nor previous type of treatment was 
revealed to the analysts. Categories were charted with entries 
from several respondents, and charts were mapped to define 
concepts and find associations between themes, with a view 
to providing explanations for the findings.
Results
Eight women from the original study had died during the 
2 years since completing their acupuncture treatment. 
Twenty-one women did not return written statements. A total 
of 61 statements were received; 33 of these women had pre-
viously been treated with TCM acupuncture, and the other 
28 had received sham acupuncture. The mean age of the 
participants was 51.3 (52.5 in the TCM group and 50.2 in the 
control group). The women provided their answers by mail. 
These were anonymously assessed by the first author and an 
oncology nurse, both experienced in research methods. The 
women also completed a validated Kupperman   menopausal 
index, examining the severity of any symptoms often 
  associated with menopause, and a questionnaire aimed at 
gathering information about symptom development. Patients 
answered five questions about: treatments in connection with 
their diagnosis, hot flash severity, whether they had had more 
acupuncture or other treatments (including medication) for 
their hot flash problems, and whether they still used the same 
estrogen-antagonist medication, had changed to another, 
or stopped. This data will be published at a later date in a 
quantitative article.
The women returned statements about their experiences 
relating to their breast cancer diagnosis, acupuncture treat-
ment for hot flashes, related symptoms, and side effects of 
estrogen-antagonist treatment, and their daily life. There 
was great variation in style, and the length of their state-
ments ranged from 0 to 364 words; the number of words in 
both groups was comparable. Statements were analyzed by 
systematic text condensation.
Although the question posed to the participants did not 
specifically mention hot flashes or acupuncture, 28 of the 
61 participants commented on one or both. Fifteen patients, 
previously treated with traditional acupuncture for their hot 
flashes, commented on the positive effects they had experi-
enced during and after treatment. Most went on to describe 
the quality and quantity of their hot flashes; 10 mentioned 
that they were still fewer and milder than they had been 
before they received treatment. Comments included: “The 
hot flashes have returned but only slightly at night, but they 
are over quickly and I have got used to them”. “My family 
saw a change in me when the hot flashes started to lessen 
during acupuncture treatment, I went back to work again, my 
colleagues are important to me. During the last 2 years I have 
had some top up treatments, and will in the future if I start to 
get warm again”. “Acupuncture helped a lot, my hot flashes 
were reduced to a level that I felt that I could manage, and 
have stayed like that”. A majority of these women went on to 
describe how they approached, or managed their hot flashes; 
techniques included avoiding situations facilitating their 
hot flashes, such as stress, certain foods and alcohol. Five 
women mentioned simple relaxation techniques as a means 
of stopping, controlling, or shortening hot flashes. Thirteen 
patients from the control group commented on acupuncture 
and level of hot flashes, though less favorably than the TCM 
group. Nine women complained of severe hot flashes, only 
one said that acupuncture had reduced her hot flashes, four 
said that acupuncture had not worked, and one commented 
that it was painful. A typical comment was: “I have strong 
and frequent hot flashes, about once an hour, I wake up 4–5 International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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times at night, even so, the hot flashes are worse during the 
day”. Another participant wrote: “I sweat a lot and have 
lots of hot flashes every day, but have learnt to tackle them, 
they don’t bother me as much, acupuncture did not work 
for me”. One lady related her hot flashes to stress at work, 
she wrote: “I work full time as a restaurant manager, I have 
lots of hot flashes, especially when I am stressed, I start to 
get warm, sweat and feel sick”. Four women mentioned that 
food and drink affects them: “I get instant hot flashes from 
fatty foods, caffeine and red wine”. Another woman wrote, 
“I found out that strong, spicy food, red wine, and chocolate 
provokes hot flashes”. One lady commented, “If I lead a 
regulated life and do not eat chocolate, I feel better, and my 
hot flashes are not as bothersome, but it is not easy, I have 
not got much will power”.
Only a total of five women mentioned their social and 
family lives, but only to demonstrate the strength of their 
symptoms; all but one were from the control group. One 
lady told how she disturbed her husband at night when she 
could not sleep; another described how shocked her friends 
were when she had a hot flash and sweat dripped down her 
face. One lady described how pleased she was to meet and 
bond with other young breast cancer patients; she felt that 
they understood each other’s problems when she attended a 
rehabilitation centre.
A total of 20 women, equally divided between the two 
groups, described how they discovered their breast tumor and 
their experiences with the health service. A young woman 
of 30 wrote: “When I was diagnosed, I decided that I would 
be in control of the disease, not the other way around. I have 
always been mentally strong and that has not changed”. 
Another wrote: “When I was diagnosed, I was not afraid, 
I felt safe at the hospital. The whole process has enriched my 
life. Although tamoxifen took all my strength and gave me 
enormous aches and pains, these disappeared when I changed 
to Arimidex [letrozole]. I can’t complain, I have a few aches 
here and there, just like other women of my age”. Another 
said: “I scratched my breast one day and felt a lump. Four 
weeks later I was operated, I tolerated the post-operative 
treatment well. I tell my friends that I am not sick, I just have 
a few problems”. Most women who mentioned the health ser-
vice seemed pleased with the service and personnel. Only two 
complained, both about their general practitioners; they both 
said that their doctors did not understand their complaints of 
side effects due to anti-estrogen medication and did not have 
time to listen to them. Another wrote that she was comforted 
when the surgeon said pre-operatively that she would be 
totally healthy again, she also said that she had confidence 
in all the hospital personnel. One participant wrote: “Being 
diagnosed with breast cancer was a shock, but much worse 
were the side effects of tamoxifen, hot flashes 3–4 times an 
hour, day and night, I was tired out, my quality of life was 
zero. Thanks to my doctor at the breast centre I was referred 
to acupuncture treatment, my hot flashes gradually reduced 
and I got some sleep”.
A lot of women, more than 50% from both groups, wrote 
about side effects of their estrogen-antagonist medication. 
Apart from hot flashes and sweating, sleep problems and 
tiredness were a big problem, followed by arm edema, muscle 
and joint pain, body weight increase, headaches, and dry 
vaginal mucus membranes. One young lady wrote: “I have 
always been strong and in good shape, but not anymore. My 
body aches, in a way I cannot describe, my joints ache. My 
fingers are stiff, it takes time for them to warm up and they 
stiffen quickly when I use them”. Many women used the 
word exhausted, a total of 16 patients either complained of 
sleep problems or of being tired. “I am weary and tired all the 
time, even though I sleep for a few hours after work”. Another 
stated: “Hot flashes, edema in my arm, sleep problems and 
tiredness has reduced my quality of life and ability to work”. 
One tired lady wrote: “I am exhausted, I did not receive any 
information on how the side-effects of the chemotherapy and 
medicines would affect me, I have had a hard time explaining 
these problems to the social services and my work place. As 
far as I know, these side-effects have not been documented, 
they need to be. I am a single mother and have had to tackle 
periods of depression, lack of sleep, hot flashes and fatigue 
alone, it has been really hard”. Vaginal dryness, a side effect 
of estrogen reduction was mentioned by several women. One 
wrote: “It is very uncomfortable, my vagina is dry, I have 
had numerous urine infections, and I bleed when I have 
sex”. Another lady wrote, “my sex life is over!” A third lady 
commented: “I have lost my sex drive, my husband and I are 
not as close now as we used to be, I put this down to lack of 
intimacy”. A total of 20 women mentioned more than two 
side effects in their statements, indicating that these problems 
are of great importance to them.
On a positive note, many women had come to terms with 
their situation; many commented that despite their health 
problems, they were happy and content. A total of 18 patients 
(13 from the traditional acupuncture group and five from the 
control group) ended their statements on a happy note. Com-
ments included: “I am OK. I am certain that I have received 
the best treatment in the world”, “Despite my breast cancer 
diagnosis, my life is positive, I am fine”, “I am healthy, the 
only thing I cannot do is go topless on the beach”. “I have International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
Dovepress 
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learnt to live with my problems. I cannot complain, it could 
be much worse. I am good”. “Ok, so I have lost my sex drive, 
got gum disease and tendinitis, but I am alive and happy”.
Discussion
Our results present information describing quality of life, 
coping mechanisms, and experiences in women operated 
for breast cancer. Women made statements about their situ-
ation in response to an open question 2 years after finishing 
acupuncture treatment (TCM or sham) for hot flashes, a 
side effect of anti-estrogen medicines. The variety of the 
written statements made by the women, although unstruc-
tured, included similar consistent themes, indicating that the 
question had been understood adequately. By posing such an 
open question, and consequently receiving unstructured state-
ments, categorizing proved problematic. However, themes 
were established by repeated statements about the same 
subjects, but with some variation. In the original acupunc-
ture trial 2 years previously, participants were randomized 
to treatment with TCM acupuncture and sham acupuncture 
(control). Those originally included in the TCM group who 
mentioned hot flashes and/or acupuncture in their statements, 
did so favorably, reporting fewer hot flashes, better hot 
flash management, and a positive attitude to acupuncture. 
Those who had originally been included in the control group 
complained more of the severity and frequency of their hot 
flashes; their attitude to acupuncture was generally less 
positive than the other group. Since acupuncture intervention 
reduced the amount of hot flashes significantly in the TCM 
group, and showed only minimal effect in the control group 
2 years earlier, it is not surprising that participants from the 
TCM group view acupuncture more favorably than those 
from the control group. But what of their hot flash complaints 
and problems? The women from the control group reported 
either more frequent and/or more intense hot flashes than the 
other group, or at least they experienced and understood their 
symptoms as severe. Could it be possible that attitude to a 
treatment and previous experience can affect symptoms and 
how we tackle them at a later date? Is it feasible to expect 
that a series of acupuncture treatments still has effect 2 years 
later?   Long-term follow up studies are few and inconclusive. 
A study from Tromsø University examining the effect of 
acupuncture 6 and 12 months after treatment in healthy meno-
pausal women could not demonstrate any long-term effect.11 
Frisk et al, however, could demonstrate a reduction in number 
of hot flashes up to 24 months after electro-acupuncture treat-
ment in breast cancer operated women.12 An explanation for 
the difference between the two groups in our study could be 
that the significant effects of acupuncture in the TCM group 
gave the women a better start, by reducing hot flashes and 
bettering sleep quality during the first few months of anti-
estrogen treatment.
Despite access to various cancer groups and societies, 
some women felt the need to talk about their diagnosis and 
time in hospital. We would not immediately have expected 
so many women to describe these experiences. Could there 
be a need for these women to get it off their chests? Might 
they have considered the questionnaire as someone to talk to 
or a good listener? Is it possible that some of these women 
have not talked to anyone about their experience in hospital 
before? Or do these women have an insatiable need to talk 
about their situation? Busy oncology departments in Norway 
do not have the luxury of a psychologist or even appointments 
meant solely for talking or discussion, general practitioners 
offer 15-minute appointments, an inadequate amount of 
time for an in-depth conversation. However, nearly all were 
positive to the health service; they communicated that they 
had confidence in and trusted the healthcare professionals 
that they came into contact with. General emotional and 
informational support by health professionals was shown 
to have a direct effect on quality of life in a study of 250 
Chinese breast cancer patients.13
Nearly half of the women in our study commented on 
symptoms they consider to be side effects of anti-estrogen 
medication. The recommended duration of hormonal therapy is 
5 years. With such a long course of therapy, adverse effects can 
cause a major decrease in the quality of life. In a bibliographic 
review of literature covering all publications that appeared in 
English language in biomedical journals between 1974 and 
2007, Montazeri examined the quality of life in breast cancer 
patients. The literature indicated that adjuvant hormonal thera-
pies negatively affected quality of life; symptoms included arm 
pain, fatigue, and postmenopausal problems. Psychological 
anxiety and depression were common among breast cancer 
patients, even years after the disease diagnosis and treatment.14 
The statements written by the women in our study confirm 
these findings and range of symptoms. Our original study 
showed a clear relationship between hot flashes, sleep prob-
lems, and depression. Acupuncture had a significant effect on 
all these symptoms. Only patients medicated with tamoxifen 
were included in the original study. In line with international 
guidelines, postmenopausal women switch to an aromatase 
antagonist after 2 years. Forty-two percent of the women (19% 
in the TCM group and 23% in the control group) had, during 
the 2-year gap between the time they finished   treatment and 
the time they made their statements, switched to an aromatase International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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antagonist. A study from the University of Sussex examined 
the quality of life of women with breast cancer, medicated 
with either tamoxifen, anastrozole (aromatase antagonist), or 
a combination of the two. A gradual improvement in qual-
ity of life during a 2-year period was reported by over 800 
women. Endocrine symptoms increased between baseline 
and 3 months for all groups, and stabilized thereafter. Patients 
taking anastrozole only, reported significantly fewer cold 
sweats and vaginal discharge, but more vaginal dryness, pain-
ful intercourse, and loss of sexual interest, than those taking 
only tamoxifen.15 Garreau et al found, by questioning over 
300 women, that those taking an aromatase inhibitor suffered 
more from musculoskeletal problems and were more likely 
to switch therapy than those taking tamoxifen.16 Side effects 
of estrogen-antagonist treatment affect many aspects of these 
women’s lives. These problems need to be addressed. Many 
women complain of not being able to move forward in their 
lives, being constantly reminded of their cancer diagnosis by 
irritating symptoms. A comfort to some will be evidence from 
the University Hospital, Groningen, The Netherlands, indicat-
ing that symptoms decreased significantly after discontinua-
tion of tamoxifen, although hot flashes, sleep disturbances, 
and vaginal dryness persisted in those treated with high-dose 
chemotherapy.17
The findings in this study represent life experiences 
associated with breast cancer diagnosis and treatment, in 
a selected group of Norwegian women. Norway is one of 
the world’s richest countries; it provides heavily subsidized 
healthcare, and women’s rights are strong. These findings are 
therefore probably not transferable to other cultures and parts 
of the world. In hindsight we regret not obtaining data about 
psychological variables, since personality traits may affect 
approach, expectations, and reactions to diagnosis, treatments, 
and coping mechanisms. Interviews, discussions, and focus 
group data may have provided more depth; however, this 
study provided us with subjective information about quality 
of life, as experienced by women who have undergone treat-
ment for breast cancer. These findings reinforce our belief 
that the side effects of anti-estrogen therapy should receive 
more attention in medical worlds of both East and West. For 
many years, medicine in the West has focused largely on 
prevention, operative, and conventional postoperative treat-
ment of breast cancer, and women have put up with adverse 
effects of long-term anti-estrogen medication. This study 
highlights the need for more quantitative and qualitative stud-
ies examining problems facing women diagnosed with breast 
cancer,   providing solutions for evidence-based treatments, 
  psychosocial interventions, and allocation of resources.
Conclusion
This study suggests that side effects of estrogen-antagonist 
treatment are a significant problem for women diagnosed with 
breast cancer, affecting their quality of life. Although patients 
who had 2 years earlier been treated with TCM acupuncture 
complained less of hot flashes, and generally seemed to have 
a more positive outlook on life, they were as troubled by other 
side effects as the women in the control group.
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